Vedolizumab Biosimilar - Research Grade,ichor.bio,ICH4035
Detects human Integrin alpha 4 + beta 7. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Vedolizumab.
Host
Humanized
Reactivity
Human
Platform ID
BAB765199408
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameVedolizumab Biosimilar - Research Grade
Cat. No.ICH4035
Accession NumberP13612
HostHumanized
IsotypeHuman IgG1
ReactivityHuman
Concentration1.0 - 5.0 mg/ml
TargetIntegrin alpha 4 + beta 7
Purity>95% by SDS-PAGE and HPLC
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml
ICH3002-100ml
ICH3003-100ml
StorageStable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory StatusFor research use only
Scientific Background
Vedolizumab, an integrin receptor antagonist, is a humanized IgG1 monoclonal antibody produced in Chinese hamster ovary cells that binds to the human _4_7 integrin. Vedolizumab has an approximate molecular weight of 147 kilodaltons.
Synonyms
ITGA4, ITGB7
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.